Register information Protection certificate

DE file number : 12 2014 000 037.9 (Status: not pending/lapsed, Query started: April 24, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTNot pending/lapsed
21DE file number DAKZ12 2014 000 037.9
UseVZMedicinal products
95Product nameTIEZThrombin, Fibrinogen und oxidierte regenerierte Cellulose
54Title of basic patentTIGZVERSTÄRKTER RESORBIERBARER MEHRSCHICHTIGER HÄMOSTATISCHER WUNDVERBAND UND HERSTELLUNGSVERFAHREN
51IPC main classICM
(ICMV)		 A61L 15/32 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61L 15/64 (2006.01)
94Start of term of protectionLBOct 18, 2025
22DE application dateDATMar 24, 2014
Date of publication of application for a certificateOTJun 5, 2014
71/73Applicant/ownerINHEthicon, Inc., U.S. Route 22, Somerville, N.J., US; Omrix Biopharmaceuticals, Inc., Rhode St. Genese, BE
74RepresentativeVTRUexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE
Address for service Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE
Patent division in charge 44
68DE file number of basic patentGAKZ60 2005 035 708.4
68EP file number of basic patentGEAKZ05 81 3133.5
43Date of first publicationEVTJun 5, 2014
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommision
EU/1/13/868
2013-09-25
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommision
EU
EU/1/13/868
2013-09-25
Date of the first transfer into DPMAregisterEREGTJun 5, 2014
Date of the (most recent) update in DPMAregisterREGTAug 12, 2024
(Show all update days)(Hide all update days)
  • Aug 12, 2024
    • St.36: changed (technical change)
  • Apr 20, 2023; Mar 16, 2023; Jan 25, 2022; Jul 16, 2019; Sep 21, 2016; Jun 11, 2016; Oct 27, 2015; Jul 11, 2015; Sep 30, 2014; Jul 6, 2014
    • Historical data not available for this/these date(s)
  • Jun 5, 2014
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Apr 25, 2014 Jun 5, 2014 Details anzeigen
2 New applicant/owner details New applicant/owner details Apr 25, 2014  Details anzeigen
3 New applicant/owner details New applicant/owner details Sep 29, 2014  Details anzeigen
4 Supplementary protection certificate procedure The application was withdrawn/the IP right was waived Mar 14, 2023 Apr 20, 2023 Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTApr 25, 2014
Issue numberHN23
YearPJ2014
Publication dateVTJun 5, 2014
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ60 2005 035 708.4
68EP file number of basic patentGEAKZ05 81 3133.5
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTApr 25, 2014
71/73Applicant/ownerINHEthicon, Inc., Somerville, N.J., US; Omrix Biopharmaceutical, Inc., Rhode-st-Genese, BE
71/73Previous applicant/ownerINHFEthicon, Inc., New Jersey, US, Omrix Biopharmaceutical, Inc., Rhode-st-Genese, BE
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 29, 2014
71/73Applicant/ownerINHEthicon, Inc., Somerville, N.J., US; Omrix Biopharmaceuticals, Inc., Rhode St. Genese, BE
71/73Previous applicant/ownerINHFEthicon, Inc., Somerville, N.J., US, Omrix Biopharmaceutical, Inc., Rhode-st-Genese, BE
View procedures Supplementary protection certificate procedure (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTThe application was withdrawn/the IP right was waived
Date of legal/procedural statusVSTTMar 14, 2023
Issue numberHN16
YearPJ2023
Publication dateVTApr 20, 2023
Type of publicationPARTBibliographic data
PartHTPart 7
Date of update of the procedureREGTApr 20, 2023